Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Springer"" wg kryterium: PB


Tytuł:
A Retrospective Analysis of Central and Peripheral Metabolic Characteristics in Patients with Cryptococcal Meningitis.
Autorzy:
Qin J; The Fourth People's Hospital of Nanning, 1 Chang-Gang-Two-Li Road, Nanning, Guangxi, 530023, People's Republic of China.
Nong L; The Fourth People's Hospital of Nanning, 1 Chang-Gang-Two-Li Road, Nanning, Guangxi, 530023, People's Republic of China.
Zhu Q; The Fourth People's Hospital of Nanning, 1 Chang-Gang-Two-Li Road, Nanning, Guangxi, 530023, People's Republic of China.
Huang Z; The Fourth People's Hospital of Nanning, 1 Chang-Gang-Two-Li Road, Nanning, Guangxi, 530023, People's Republic of China.
Wu F; The Fourth People's Hospital of Nanning, 1 Chang-Gang-Two-Li Road, Nanning, Guangxi, 530023, People's Republic of China.
Li S; The Fourth People's Hospital of Nanning, 1 Chang-Gang-Two-Li Road, Nanning, Guangxi, 530023, People's Republic of China. .
Pokaż więcej
Źródło:
Neurology and therapy [Neurol Ther] 2024 Apr 20. Date of Electronic Publication: 2024 Apr 20.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Group-Based Trajectory Modeling of Fluid Balance in Elderly Patients with Acute Ischemic Stroke: Analysis from Multicenter ICUs.
Autorzy:
Tang J; Graduate School of Xinjiang Medical University, Urumqi, Xinjiang, China.
Wu C; Xinjiang Emergency Center, People's Hospital of Xinjiang Uygur Autonomous Region, No. 91, Tian-Chi Road, Tianshan District, Urumqi, 830001, Xinjiang, China. .
Zhong Z; Department of Bioengineering, Imperial College London, London, UK.
Pokaż więcej
Źródło:
Neurology and therapy [Neurol Ther] 2024 Apr 18. Date of Electronic Publication: 2024 Apr 18.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
The Epidemiology of Hospital-Treated Alopecia Areata in Denmark, 1995-2016.
Autorzy:
Sørensen SBT; Department of Clinical Medicine and Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Olof Palmes Allé 43-45, 8200, Aarhus N, Denmark.
George P; Pfizer Inc., New York, NY, USA.
Jagun O; Pfizer Inc., New York, NY, USA.
Wolk R; Pfizer Inc., Groton, CT, USA.
Napatalung L; Pfizer Inc., New York, NY, USA.; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Zwillich SH; Pfizer Inc., Groton, CT, USA.
Iversen L; Department of Dermatology, Aarhus University Hospital and Aarhus University, Aarhus N, Denmark.; MC2 Therapeutics A/S, Hørsholm, Denmark.
Ehrenstein V; Department of Clinical Medicine and Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Olof Palmes Allé 43-45, 8200, Aarhus N, Denmark. .
Pokaż więcej
Źródło:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2024 Apr 16. Date of Electronic Publication: 2024 Apr 16.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Chinese Translation and Validation of the Center for Neurologic Study Lability Scale.
Autorzy:
Chen L; Department of Neurology, Peking University Third Hospital, Haidian District, 49 North Garden Road, Beijing, 100191, China.; Department of Neurology, Yan'an Hospital of Traditional Chinese Medicine, No. 26 Xuan Yuan Road, Bridge Ditch Street, Bao Ta District, Yan'an, 716000, Shaanxi Province, China.
Ye S; Department of Neurology, Peking University Third Hospital, Haidian District, 49 North Garden Road, Beijing, 100191, China.
Murphy D; Center for Neurological Study in La Jolla, 7590 Fay Avenue, Suite 517, La Jolla, CA, USA.
Wu J; Department of Neurology, Peking University Third Hospital, Haidian District, 49 North Garden Road, Beijing, 100191, China.
Zhang H; Department of Neurology, Peking University Third Hospital, Haidian District, 49 North Garden Road, Beijing, 100191, China.
Liu H; Department of Neurology, Peking University Third Hospital, Haidian District, 49 North Garden Road, Beijing, 100191, China.
Zou B; Department of Neurology, Peking University Third Hospital, Haidian District, 49 North Garden Road, Beijing, 100191, China.
Hou G; Department of Neurology, Peking University Third Hospital, Haidian District, 49 North Garden Road, Beijing, 100191, China.
Zhang N; Department of Neurology, Peking University Third Hospital, Haidian District, 49 North Garden Road, Beijing, 100191, China.
Yin T; Department of Neurology, Peking University Third Hospital, Haidian District, 49 North Garden Road, Beijing, 100191, China.
Smith RA; Center for Neurological Study in La Jolla, 7590 Fay Avenue, Suite 517, La Jolla, CA, USA. .
Fan D; Department of Neurology, Peking University Third Hospital, Haidian District, 49 North Garden Road, Beijing, 100191, China. .; Key Laboratory for Neuroscience, National Health Commission/Ministry of Education, Peking University, 38 Xueyuan Road, Haidian District, Beijing, 100191, China. .; Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing, 100191, China. .
Pokaż więcej
Źródło:
Neurology and therapy [Neurol Ther] 2024 Apr 16. Date of Electronic Publication: 2024 Apr 16.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Vascular Endothelial Growth Factor and Ischemic Stroke Risk: A Mendelian Randomization Study.
Autorzy:
Zhang X; Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Beijing, 100053, China.; Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK.; China International Neuroscience Institute (China-INI), 45 Changchun Street, Beijing, 100053, China.
Hu X; Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, 100730, China.
Fang S; Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, 100730, China.; Department of Neurology, Peking Union Medical College Hospital, Beijing, 100730, China.
Li J; Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Beijing, 100053, China.; China International Neuroscience Institute (China-INI), 45 Changchun Street, Beijing, 100053, China.
Liu Z; Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK.
Xie W; Department of Computer Science, City University of Hong Kong, Kowloon, 999077, Hong Kong SAR.
Xu R; Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Beijing, 100053, China.; China International Neuroscience Institute (China-INI), 45 Changchun Street, Beijing, 100053, China.
Dmytriw AA; Neuroendovascular Program, Massachusetts General Hospital, Boston, MA, 02114, USA.
Yang K; Department of Neurosurgery, Tai'an Central Hospital, 29 Longtan Road, Tai'an, 271000, Shandong, China.
Ma Y; Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Beijing, 100053, China.; China International Neuroscience Institute (China-INI), 45 Changchun Street, Beijing, 100053, China.
Jiao L; Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Beijing, 100053, China. .; China International Neuroscience Institute (China-INI), 45 Changchun Street, Beijing, 100053, China. .; Department of Interventional Neuroradiology, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Xicheng District Beijing, 100053, China. .
Wang T; Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Beijing, 100053, China. wangtao_.; China International Neuroscience Institute (China-INI), 45 Changchun Street, Beijing, 100053, China. wangtao_.
Pokaż więcej
Źródło:
Neurology and therapy [Neurol Ther] 2024 Apr 15. Date of Electronic Publication: 2024 Apr 15.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis.
Autorzy:
Torres T; Centro Hospitalar Universitário de Santo António, University of Porto, Porto, Portugal.
Sohrt Petersen A; LEO Pharma A/S, Industriparken 55, 2750, Ballerup, Denmark. .
Ivens U; LEO Pharma A/S, Industriparken 55, 2750, Ballerup, Denmark.
Bosch Vilaro A; LEO Pharma A/S, Industriparken 55, 2750, Ballerup, Denmark.
Stinson J; LEO Pharma A/S, Industriparken 55, 2750, Ballerup, Denmark.
Carrascosa JM; Hospital Universitari Germans Trias I Pujol, UAB, IGTP, Badalona, Spain.
Pokaż więcej
Źródło:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2024 Apr 13. Date of Electronic Publication: 2024 Apr 13.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Novel Topical Treatments for Itch.
Autorzy:
Mahmoud RH; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miami Itch Center, University of Miami Miller School of Medicine, 5555 Ponce de Leon, Coral Gables, FL, 33146, USA.
Mahmoud O; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miami Itch Center, University of Miami Miller School of Medicine, 5555 Ponce de Leon, Coral Gables, FL, 33146, USA.
Biazus Soares G; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miami Itch Center, University of Miami Miller School of Medicine, 5555 Ponce de Leon, Coral Gables, FL, 33146, USA.
Yosipovitch G; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miami Itch Center, University of Miami Miller School of Medicine, 5555 Ponce de Leon, Coral Gables, FL, 33146, USA. .
Pokaż więcej
Źródło:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2024 Apr 13. Date of Electronic Publication: 2024 Apr 13.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Tytuł:
Current Diagnostic and Therapeutic Practices in Alopecia Areata in Two Mediterranean Countries: A Survey-Based Study.
Autorzy:
Starace M; Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Massarenti 1, 40138, Bologna, Italy.; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
Pampaloni F; Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Massarenti 1, 40138, Bologna, Italy.; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
Lazaridou E; Second Dermatology Department, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Kyrmanidou E; Second Dermatology Department, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Stratigos A; 1st Department of Dermatology and Venereology, Medical School, National and Kapodistrian University of Athens, 'A. Sygros' Hospital for Skin and Venereal Diseases, Athens, Greece.
Lallas A; 1st Department of Dermatology and Venereology, Medical School, Aristotle University of Thessaloniki, Thessaloníki, Greece.
Katoulis A; 2nd Department of Dermatology and Venereology, Medical School, National and Kapodistrian University of Athens, 'Attiko' General Hospital, Athens, Greece.
Sgouros D; 2nd Department of Dermatology and Venereology, Medical School, National and Kapodistrian University of Athens, 'Attiko' General Hospital, Athens, Greece.
Quadrelli F; Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Massarenti 1, 40138, Bologna, Italy.; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
Rapparini L; Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Massarenti 1, 40138, Bologna, Italy.; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
Cedirian S; Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Massarenti 1, 40138, Bologna, Italy.; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
Bruni F; Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Massarenti 1, 40138, Bologna, Italy.; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
Ala L; Dermatologic Unit, Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, La Sapienza University of Rome, Rome, Italy.
Rossi A; Dermatologic Unit, Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, La Sapienza University of Rome, Rome, Italy.
Piraccini BM; Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Massarenti 1, 40138, Bologna, Italy. .; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy. .
Apalla Z; Second Dermatology Department, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Pokaż więcej
Źródło:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2024 Apr 10. Date of Electronic Publication: 2024 Apr 10.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Letter to the Editor Regarding: Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study.
Autorzy:
Hu R; Department of Rheumatology, Fangshan Hospital Beijing University of Chinese Medicine, Beijing, China.
Wang Y; Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, China.
Meng F; School of Clinical Medicine, Beijing University of Chinese Medicine, Beijing, China.
Lin Z; Beijing University of Chinese Medicine, Beijing, China.
Chen N; Department of Radiology, Fangshan Hospital Beijing University of Chinese Medicine, Beijing, China.
Li C; Department of Rheumatology, Fangshan Hospital Beijing University of Chinese Medicine, Beijing, China. .
Pokaż więcej
Źródło:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2024 Apr 09. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:
Letter; Comment
Opinia redakcyjna
Tytuł:
Publisher Correction to: Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry.
Autorzy:
Simpson EL; Department of Dermatology, Oregon Health and Science University, Portland, OR, USA. .
Lockshin B; Department of Dermatology, Georgetown University, Washington, DC, USA.
Lee LW; Medical University of South Carolina, Charleston, SC, USA.
Chen Z; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
Daoud M; Sanofi, Cambridge, MA, USA.
Korotzer A; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
Pokaż więcej
Źródło:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2024 Apr 09. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:
Published Erratum
Tytuł:
Psoriasis and Molecular Target Therapies: Evidence of Efficacy in Preventing Cardiovascular Comorbidities.
Autorzy:
Potestio L; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy. .
Tommasino N; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy.
Lauletta G; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy.
Martora F; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy.
Megna M; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy.
Pokaż więcej
Źródło:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2024 Apr 09. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Tytuł:
Methotrexate and the Risk of Dementia: A Two-Sample Mendelian Randomization Study.
Autorzy:
Ma XN; State Key Laboratory of Traditional Chinese Medicine Syndrome, The First Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.; Department of Rheumatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Feng W; State Key Laboratory of Traditional Chinese Medicine Syndrome, The First Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.; Department of Rheumatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Chen SL; State Key Laboratory of Traditional Chinese Medicine Syndrome, The First Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.; Department of Rheumatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Zhong XQ; State Key Laboratory of Traditional Chinese Medicine Syndrome, The First Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.; Department of Rheumatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Lin CS; State Key Laboratory of Traditional Chinese Medicine Syndrome, The First Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. .; Department of Rheumatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. .
Xu Q; State Key Laboratory of Traditional Chinese Medicine Syndrome, The First Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. .; Department of Rheumatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. .
Pokaż więcej
Źródło:
Neurology and therapy [Neurol Ther] 2024 Apr 09. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Narrative Review on the Use of Cladribine Tablets as Exit Therapy for Stable Elderly Patients with Multiple Sclerosis.
Autorzy:
de Seze J; Department of Neurology, Strasbourg University Hospital, Strasbourg, France. .
Dive D; Department of Neurology, Liège University Hospital, Liège, Belgium.
Ayrignac X; Department of Neurology, University of Montpellier, INM, INSERM, Montpellier University Hospital, Montpellier, France.
Castelnovo G; Department of Neurology, Nîmes University Hospital, Hopital Caremeau, Nîmes, France.
Payet M; Merck Santé S.A.S., an Affiliate of Merck KGaA, Lyon, France.
Rayah A; Merck Santé S.A.S., an Affiliate of Merck KGaA, Lyon, France.
Gobbi C; Multiple Sclerosis Center, Neurocenter of Southern Switzerland, EOC, Lugano, Switzerland.; Faculty of Biomedical Sciences, Università Della Svizzera Italiana, Lugano, Switzerland.
Vermersch P; University of Lille, INSERM U1172 LilNCog, CHU Lille, FHU Precise, Lille, France.
Zecca C; Multiple Sclerosis Center, Neurocenter of Southern Switzerland, EOC, Lugano, Switzerland.; Faculty of Biomedical Sciences, Università Della Svizzera Italiana, Lugano, Switzerland.
Pokaż więcej
Źródło:
Neurology and therapy [Neurol Ther] 2024 Apr 08. Date of Electronic Publication: 2024 Apr 08.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Tytuł:
Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension Study.
Autorzy:
Takeshima T; Headache Center, Department of Neurology, Tominaga Hospital, Osaka, Japan.
Doi H; Doi Clinic Internal Medicine/Neurology, Hiroshima, Japan.
Ooba S; Department of Neurosurgery and Headache, Ooba Clinic, Oita, Japan.
Tanji Y; Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., 5-1-28, Isogamidori, Chuo-ku, Kobe, 651-0086, Japan.
Ozeki A; Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., 5-1-28, Isogamidori, Chuo-ku, Kobe, 651-0086, Japan.
Komori M; Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., 5-1-28, Isogamidori, Chuo-ku, Kobe, 651-0086, Japan. komori_.
Pokaż więcej
Źródło:
Neurology and therapy [Neurol Ther] 2024 Apr 06. Date of Electronic Publication: 2024 Apr 06.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Donanemab in Japanese Patients with Early Alzheimer's Disease: Subpopulation Analysis of the TRAILBLAZER-ALZ 2 Randomized Trial.
Autorzy:
Sato S; Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., 5-1-28, Isogamidori, Chuo-Ku, Kobe, 651-0086, Japan. sato_.
Hatakeyama N; Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., 5-1-28, Isogamidori, Chuo-Ku, Kobe, 651-0086, Japan.
Fujikoshi S; Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., 5-1-28, Isogamidori, Chuo-Ku, Kobe, 651-0086, Japan.
Katayama S; Katayama Medical Clinic, Kurashiki, Japan.
Katagiri H; Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., 5-1-28, Isogamidori, Chuo-Ku, Kobe, 651-0086, Japan.
Sims JR; Eli Lilly and Company, Indianapolis, IN, USA.
Pokaż więcej
Źródło:
Neurology and therapy [Neurol Ther] 2024 Apr 06. Date of Electronic Publication: 2024 Apr 06.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Response to: Letter to Editor Regarding "Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study".
Autorzy:
Burden AD; School of Infection and Immunity, University of Glasgow, Glasgow, UK. .
Pokaż więcej
Źródło:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2024 Apr 05. Date of Electronic Publication: 2024 Apr 05.
Typ publikacji:
Letter
Opinia redakcyjna
Tytuł:
Clinical Characteristics and Therapeutic Aspects of Blaschko Linear Psoriasis.
Autorzy:
Chen L; Department of Dermatology, Daping Hospital, Army Medical University, Chongqing, 400042, China.
Cheng Y; Department of Dermatology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, No. 106, Zhongshan 2nd Road, Guangzhou, 510080, Guangdong, China.
Peng L; Department of Dermatology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, No. 106, Zhongshan 2nd Road, Guangzhou, 510080, Guangdong, China.
Jia X; Department of Dermatology, The First Affiliated Hospital of Shihezi University, Xinjiang, 832008, China.
Liu G; Department of Dermatology, Daping Hospital, Army Medical University, Chongqing, 400042, China.
Shen Z; Department of Dermatology, Daping Hospital, Army Medical University, Chongqing, 400042, China. .; Department of Dermatology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, No. 106, Zhongshan 2nd Road, Guangzhou, 510080, Guangdong, China. .
Pokaż więcej
Źródło:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2024 Apr 05. Date of Electronic Publication: 2024 Apr 05.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis.
Autorzy:
Bhutani T; University of California San Francisco Health, 515 Spruce Street #101, San Francisco, CA, 94118, USA. .
Koo J; University of California San Francisco Health, 515 Spruce Street #101, San Francisco, CA, 94118, USA.
Heim J; West Michigan Dermatology, Grandville, MI, USA.
Bhatia N; Therapeutics Clinical Research, San Diego, CA, USA.
Mathew J; Sun Pharmaceutical Industries, Inc., Princeton, NJ, USA.
Ferro T; Sun Pharmaceutical Industries, Inc., Princeton, NJ, USA.
Vasquez JG; West Michigan Dermatology, Grandville, MI, USA.
Pokaż więcej
Źródło:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2024 Apr 04. Date of Electronic Publication: 2024 Apr 04.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Acute Systemic Toxicity Caused by Topical Application of EMLA Cream on a Leg Ulcer: Case Report and Review of Literature.
Autorzy:
Hoffmann SM; Department of Dermatology, Medical Center, University of Freiburg, Hauptstrasse 7, 79104, Freiburg, Germany.
Hartmann AL; Department of Dermatology, Medical Center, University of Freiburg, Hauptstrasse 7, 79104, Freiburg, Germany.
Nieratschker P; University Emergency Unit, Medical Center, University of Freiburg, Sir-Hans-A.-Krebs-Strasse, 79106, Freiburg, Germany.
Mussler MB; University Emergency Unit, Medical Center, University of Freiburg, Sir-Hans-A.-Krebs-Strasse, 79106, Freiburg, Germany.
Schempp CM; Department of Dermatology, Medical Center, University of Freiburg, Hauptstrasse 7, 79104, Freiburg, Germany. .
Pokaż więcej
Źródło:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2024 Apr 03. Date of Electronic Publication: 2024 Apr 03.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease.
Autorzy:
Frank S; Beth Israel Deaconess Medical Center/Harvard Medical School, 330 Brookline Ave., Kirstein 228, Boston, MA, 02215, USA. .
Anderson KE; Georgetown University, Washington, DC, USA.
Fernandez HH; Cleveland Clinic, Cleveland, OH, USA.
Hauser RA; University of South Florida Parkinson's Disease and Movement Disorders Center, Tampa, FL, USA.
Claassen DO; Vanderbilt University Medical Center, Nashville, TN, USA.
Stamler D; Teva Branded Pharmaceutical Products R&D, Inc., La Jolla, CA, USA.
Factor SA; Emory University, Atlanta, GA, USA.
Jimenez-Shahed J; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Barkay H; Teva Pharmaceutical Industries Ltd., Netanya, Israel.
Wilhelm A; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA.
Alexander JK; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA.
Chaijale N; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA.
Barash S; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA.
Savola JM; Teva Pharmaceuticals International GmbH, Basel, Switzerland.
Gordon MF; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA.
Chen M; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA.
Pokaż więcej
Źródło:
Neurology and therapy [Neurol Ther] 2024 Apr 01. Date of Electronic Publication: 2024 Apr 01.
Typ publikacji:
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies